TAK
Takeda Pharmaceutical Company Limited
$16.43
Earnings Summary
Revenue | $430777Mn |
Net Profits | $48426Mn |
Net Profit Margins | 11.24% |
Highlights
Takeda Pharmaceutical Company Limited’s revenue fell -0.55% since last year same period to $430777Mn in the Q3 2018. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -4.24% fall in its revenue since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit jumped 72.78% since last year same period to $48426Mn in the Q3 2018. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -38.11% fall in its net profits since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit margin jumped 73.74% since last year same period to 11.24% in the Q3 2018. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -35.37% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Takeda Pharmaceutical Company Limited post its latest quarter earnings
EPS Estimate Current Quarter | 0.15 |
EPS Estimate Current Year | 0.15 |
Highlights
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.15 - a -54.49% fall from last quarter’s estimates.
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.15.
Key Ratios
Key ratios of the Takeda Pharmaceutical Company Limited post its Q1 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Takeda Pharmaceutical Company Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2023. This indicates that the Takeda Pharmaceutical Company Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2020-01-10 | 75 | 3 | -96% |
2019-04-25 | -0.36 | -0.62 | -72.22% |
2019-10-31 | -0.21 | 0.16 | 176.19% |
2019-07-31 | -0.19 | -0.06 | 67.68% |
Company Information
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.
Organisation | Takeda Pharmaceutical Company Limited |
Headquarters | 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 |
Employees | 47347 |
Industry | Health Technology |
CEO | Christophe Weber |
